Hepatocellular Carcinoma (HCC)

Ferenci, Péter; Fried, Michael; R. LaBrecque, Douglas; Bruix, Jordi; Sherman, Morris; Omata, Masao; Heathcote, Jenny; Piratsivuth, Teehra; Kew, Mike; A Otegbayo, J; Zheng, Shi; Sarin, Saket; Hamid, Saeed; Barakat Modawi, Salma; E. Fleig, Wolfgang; S Fedail, S; Thomson, Alan; Ali Khan, Aamir; Malfertheiner, Peter; Lau, George; J. Carillo, Flair; Krabshuis, Justus; Le Mair, Anton

doi:10.1097/mcg.0b013e3181d46ef2

Public

Hepatocellular Carcinoma (HCC)

Published in Journal of Clinical Gastroenterology • Mar 19, 2010

Authors:

Péter Ferenci

Michael Fried

Douglas R. LaBrecque

Abstract

INTRODUCTION More than 600,000 people die of hepatocellular carcinoma (HCC) each year. Worldwide research on the disease needs to be intensified in both the medical and pharmaceutical fields, especially with a focus on providing help to areas where resources are limited. Treatment approaches depend ...

Subject

Medicine

Sorafenib

Hepatocellular carcinoma

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!